Fingerprint
Dive into the research topics of 'A phase I study of LY3009120, a pan-RAF inhibitor, in patients with advanced or metastatic cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase I study of LY3009120, a pan-RAF inhibitor, in patients with advanced or metastatic cancer
Ryan J. Sullivan, Antoine Hollebecque, Keith T. Flaherty, Geoffrey I. Shapiro, Jordi Rodon Ahnert, Michael J. Millward, Wei Zhang, Ling Gao, Amanda Sykes, Melinda D. Willard, Danni Yu, Andrew E. Schade, Kris Anne Crowe, Daniel L. Flynn, Michael D. Kaufman, James R. Henry, Sheng Bin Peng, Karim A. Benhadji, Ilaria Conti, Michael S. Gordon
Research output: Contribution to journal › Article › peer-review
55
Scopus
citations